We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“No anticoagulation demonstrated BEST risk-benefit profile across all outcomes (hypothesis-generating); DOAC showed dramatically elevated bleeding risk (57% CRNM, p equals 0.061 vs warfarin) without stroke benefit; Warfarin showed poorest ischemic protection (9.1% stroke rate in largest group); Antiplatelets dramatically WORSEN outcomes (5 times stroke increase, 6 times bleeding increase); Current UKKA guidance stating 'equivalence' of all strategies is challenged by these data.”
No takes yet. Share an insight, caveat, or question.
Chafekar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: